Announcement on Voluntary Disclosure of Clinical Study Cooperation with AstraZeneca
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Voluntary Disclosure of Clinical Study Cooperation with AstraZeneca
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-clinical-study-cooperation-with-astrazeneca
Release
Sichuan Huiyu Pharmaceutical Co. Ltd. on 6ix
Earlier from Sichuan Huiyu Pharmaceutical
- Announcement on Obtaining Drug Registration Certificate for Cimetidine Injection
- Announcement on Progress in Participation in Private Equity Fund Investment and Related Party Transaction
- Announcement on Obtaining Drug Registration Certificate for Nicardipine Hydrochloride Injection
- Announcement on Cooperation with Professional Institutions to Invest in the Establishment of a Private Equity Fund
- Announcement on Voluntary Disclosure of the Acceptance of IND Application for the Drug Combination Involving HYP-6589 Tablets
Later from Sichuan Huiyu Pharmaceutical
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Passive Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Expected Loss in Performance for 2025
- Announcement on Result of Passive Shareholding Reduction by Shareholder with Over 5% Shares
- Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA
Follow Sichuan Huiyu Pharmaceutical into a list and get an email when it puts out news.
Follow Sichuan Huiyu Pharmaceutical